EP2659272A4 - Biomarqueurs protéiques de cancer du sein récurrent - Google Patents

Biomarqueurs protéiques de cancer du sein récurrent

Info

Publication number
EP2659272A4
EP2659272A4 EP11853746.3A EP11853746A EP2659272A4 EP 2659272 A4 EP2659272 A4 EP 2659272A4 EP 11853746 A EP11853746 A EP 11853746A EP 2659272 A4 EP2659272 A4 EP 2659272A4
Authority
EP
European Patent Office
Prior art keywords
breast cancer
protein biomarkers
recurrent breast
recurrent
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11853746.3A
Other languages
German (de)
English (en)
Other versions
EP2659272A2 (fr
Inventor
David B Krizman
Marlene M Darfler
Thomas P Conrads
Brian L Hood
Nicholas W Bateman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Expression Pathology Inc
Original Assignee
Expression Pathology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expression Pathology Inc filed Critical Expression Pathology Inc
Publication of EP2659272A2 publication Critical patent/EP2659272A2/fr
Publication of EP2659272A4 publication Critical patent/EP2659272A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
EP11853746.3A 2010-12-29 2011-12-29 Biomarqueurs protéiques de cancer du sein récurrent Withdrawn EP2659272A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428145P 2010-12-29 2010-12-29
PCT/US2011/067996 WO2012092529A2 (fr) 2010-12-29 2011-12-29 Biomarqueurs protéiques de cancer du sein récurrent

Publications (2)

Publication Number Publication Date
EP2659272A2 EP2659272A2 (fr) 2013-11-06
EP2659272A4 true EP2659272A4 (fr) 2015-07-22

Family

ID=46383871

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11853746.3A Withdrawn EP2659272A4 (fr) 2010-12-29 2011-12-29 Biomarqueurs protéiques de cancer du sein récurrent

Country Status (5)

Country Link
EP (1) EP2659272A4 (fr)
JP (1) JP2014502729A (fr)
AU (1) AU2011351990A1 (fr)
CA (1) CA2823334A1 (fr)
WO (1) WO2012092529A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013039477A1 (fr) 2011-09-12 2013-03-21 University Of South Alabama Procédés non invasifs de détection de molécules cibles
CA2902841A1 (fr) * 2013-03-13 2014-10-02 Creatics Llc Procedes et compositions pour detecter un cancer du pancreas
CN104277102B (zh) * 2014-06-27 2017-04-12 李光辉 一种检测乳腺癌标志物Annexin A1抗原表位氨基酸序列及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090136971A1 (en) * 2005-05-25 2009-05-28 Krizman David B Multiplex liquid tissue method for increased proteomic coverage from histopathologically processed biological samples, tissues, and cells
US20090215636A1 (en) * 2005-05-25 2009-08-27 Krizman David B Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668354A2 (fr) * 2003-09-24 2006-06-14 Oncotherapy Science, Inc. Methode de diagnostic du cancer du sein
WO2007048978A2 (fr) * 2005-10-28 2007-05-03 Biomerieux Sa Procede de detection du cancer
US20090263842A1 (en) * 2006-03-24 2009-10-22 Expression Pathology Method of assessing the metastatic status of a primary tumor
US20110028344A1 (en) * 2008-04-11 2011-02-03 Expression Pathology, Inc. Biomarkers for endometrial disease
AU2009270793A1 (en) * 2008-07-18 2010-01-21 Oragenics, Inc. Compositions for the detection and treatment of colorectal cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090136971A1 (en) * 2005-05-25 2009-05-28 Krizman David B Multiplex liquid tissue method for increased proteomic coverage from histopathologically processed biological samples, tissues, and cells
US20090215636A1 (en) * 2005-05-25 2009-08-27 Krizman David B Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BATEMAN N.W. ET AL.: "Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues", J. PROTEOME RES., vol. 10, no. 3, 14 December 2010 (2010-12-14), pages 1323 - 1332, XP055063617 *
HOOD B.L. ET AL.: "Proteomic analysis of formalin-fixed prostate cancer tissue", MOL. CELL. PROTEOM., vol. 4, no. 11, 1 November 2005 (2005-11-01), pages 1741 - 1753, XP002482477 *
PRIETO D.A. ET AL.: "Liquid Tissue(TM): proteomic profiling of formalin-fixed tissues", BIOTECHNIQUES, vol. S6, June 2005 (2005-06-01), pages 32 - 35, XP055163898 *

Also Published As

Publication number Publication date
CA2823334A1 (fr) 2012-07-05
WO2012092529A2 (fr) 2012-07-05
WO2012092529A3 (fr) 2012-08-23
JP2014502729A (ja) 2014-02-03
AU2011351990A1 (en) 2013-07-18
EP2659272A2 (fr) 2013-11-06

Similar Documents

Publication Publication Date Title
IL290139A (en) Optimization of multigene analysis of tumor samples
EP2625292A4 (fr) Biomarqueurs de cancer
ZA201209390B (en) Comparison of protein samples
PT3023788T (pt) Composições de neoantigénios específicos de tumor para utilização no tratamento de tumores
IL225545A0 (en) Antibodies specific to cancerous tumors and their uses
EP2536854A4 (fr) Biomarqueurs tumoraux personnalisés
GB2513275B (en) Biomarkers for Breast Cancer Prediction and Diagnosis
IL225441A0 (en) Breast cancer diagnostics
EP2542701A4 (fr) Biomarqueurs d'arthrose
EP2698634A4 (fr) Biomarqueur pour le cancer du sein
EP2748608A4 (fr) Tests du cancer du poumon
EP2550533A4 (fr) Dépistage précoce d'un cancer du sein récurrent par profilage des métabolites
EP2707710A4 (fr) Diagnostic de cancer
GB2536374B (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
EP2600896A4 (fr) Traitement du cancer du sein avec un anticorps anti-il-19
EP2577298A4 (fr) Diagnostic du cancer
GB2510539B (en) Biomarkers of cancer
EP2531616A4 (fr) Dosage de diagnostic et de pronostic pour le cancer du sein
EP2649225A4 (fr) Biomarqueurs pour la prédiction du cancer du sein
EP2659272A4 (fr) Biomarqueurs protéiques de cancer du sein récurrent
EP2771695A4 (fr) Procédé de détection de cancers du sein
EP2501845A4 (fr) Biomarqueurs de cancer
EP2643482A4 (fr) Détection précoce du cancer du pancréas
EP2732287A4 (fr) Procédés de diagnostic du cancer
EP2658992A4 (fr) Biomarqueurs protéiques du cancer du sein de stade tardif

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130729

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20150212BHEP

Ipc: G01N 33/574 20060101AFI20150212BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20150623

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20150617BHEP

Ipc: G01N 33/574 20060101AFI20150617BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160121